Effect of Substituting Truvada for Combivir or Trizivir vs Continuing Combivir or Trizivir on Physiologic Correlates of Mitochondrial Function in Subjects Infected With Human Immunodeficiency Virus on Highly Active Antiretroviral Therapy.

Trial Profile

Effect of Substituting Truvada for Combivir or Trizivir vs Continuing Combivir or Trizivir on Physiologic Correlates of Mitochondrial Function in Subjects Infected With Human Immunodeficiency Virus on Highly Active Antiretroviral Therapy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Jan 2013

At a glance

  • Drugs Emtricitabine/tenofovir disoproxil fumarate; Lamivudine/zidovudine; Lamivudine/zidovudine/abacavir
  • Indications HIV infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 21 Sep 2011 Additional trial lead investigator added as reported by ClinicalTrials.gov.
    • 27 Aug 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top